Hill SA - Search Results

1

Determinants of anti-vascular action by combretastatin A-4 phosphate: role of nitric oxide.

Parkins CS, Holder AL, Hill SA, Chaplin DJ, Tozer GM. Parkins CS, et al. Among authors: hill sa. Br J Cancer. 2000 Sep;83(6):811-6. doi: 10.1054/bjoc.2000.1361. Br J Cancer. 2000. PMID: 10952787 Free PMC article.

2

Nitric oxide synthase inhibition enhances the tumor vascular-damaging effects of combretastatin a-4 3-o-phosphate at clinically relevant doses.

Tozer GM, Prise VE, Lewis G, Xie S, Wilson I, Hill SA. Tozer GM, et al. Among authors: hill sa. Clin Cancer Res. 2009 Jun 1;15(11):3781-90. doi: 10.1158/1078-0432.CCR-08-2906. Epub 2009 May 26. Clin Cancer Res. 2009. PMID: 19470729 Free article.

3

Vascular effects dominate solid tumor response to treatment with combretastatin A-4-phosphate.

Lunt SJ, Akerman S, Hill SA, Fisher M, Wright VJ, Reyes-Aldasoro CC, Tozer GM, Kanthou C. Lunt SJ, et al. Among authors: hill sa. Int J Cancer. 2011 Oct 15;129(8):1979-89. doi: 10.1002/ijc.25848. Epub 2011 Apr 13. Int J Cancer. 2011. PMID: 21154772

4

The biology of the combretastatins as tumour vascular targeting agents.

Tozer GM, Kanthou C, Parkins CS, Hill SA. Tozer GM, et al. Among authors: hill sa. Int J Exp Pathol. 2002 Feb;83(1):21-38. doi: 10.1046/j.1365-2613.2002.00211.x. Int J Exp Pathol. 2002. PMID: 12059907 Free PMC article. Review.

5

Schedule dependence of combretastatin A4 phosphate in transplanted and spontaneous tumour models.

Hill SA, Chaplin DJ, Lewis G, Tozer GM. Hill SA, et al. Int J Cancer. 2002 Nov 1;102(1):70-4. doi: 10.1002/ijc.10655. Int J Cancer. 2002. PMID: 12353236

6

Anti-vascular approaches to solid tumour therapy: evaluation of vinblastine and flavone acetic acid.

Hill SA, Sampson LE, Chaplin DJ. Hill SA, et al. Int J Cancer. 1995 Sep 27;63(1):119-23. doi: 10.1002/ijc.2910630121. Int J Cancer. 1995. PMID: 7558438

7

Temporal heterogeneity in microregional erythrocyte flux in experimental solid tumours.

Chaplin DJ, Hill SA. Chaplin DJ, et al. Among authors: hill sa. Br J Cancer. 1995 Jun;71(6):1210-3. doi: 10.1038/bjc.1995.235. Br J Cancer. 1995. PMID: 7779713 Free PMC article.

8

Ischemia reperfusion injury in tumors: the role of oxygen radicals and nitric oxide.

Parkins CS, Dennis MF, Stratford MR, Hill SA, Chaplin DJ. Parkins CS, et al. Among authors: hill sa. Cancer Res. 1995 Dec 15;55(24):6026-9. Cancer Res. 1995. PMID: 8521386

9

Antivascular approaches to solid tumour therapy: evaluation of tubulin binding agents.

Chaplin DJ, Pettit GR, Parkins CS, Hill SA. Chaplin DJ, et al. Among authors: hill sa. Br J Cancer Suppl. 1996 Jul;27:S86-8. Br J Cancer Suppl. 1996. PMID: 8763854 Free PMC article.

10

Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature.

Dark GG, Hill SA, Prise VE, Tozer GM, Pettit GR, Chaplin DJ. Dark GG, et al. Among authors: hill sa. Cancer Res. 1997 May 15;57(10):1829-34. Cancer Res. 1997. PMID: 9157969

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters